Calumet Specialty Products Partners, L.P.

NasdaqGS:CLMT Stock Report

Market Cap: US$1.3b

Calumet Specialty Products Partners Balance Sheet Health

Financial Health criteria checks 0/6

Calumet Specialty Products Partners has a total shareholder equity of $-244.7M and total debt of $2.1B, which brings its debt-to-equity ratio to -847.1%. Its total assets and total liabilities are $2.8B and $3.0B respectively. Calumet Specialty Products Partners's EBIT is $263.2M making its interest coverage ratio 1.2. It has cash and short-term investments of $7.9M.

Key information

-847.1%

Debt to equity ratio

US$2.07b

Debt

Interest coverage ratio1.2x
CashUS$7.90m
Equity-US$244.70m
Total liabilitiesUS$3.00b
Total assetsUS$2.75b

Recent financial health updates

No updates

Recent updates

Investors Will Want Calumet Specialty Products Partners' (NASDAQ:CLMT) Growth In ROCE To Persist

Apr 01
Investors Will Want Calumet Specialty Products Partners' (NASDAQ:CLMT) Growth In ROCE To Persist

Calumet Specialty Products: Huge Increases In Cash Flows May Be Imminent [Downgrade]

Mar 18

LVS Advisory - Calumet: Fits Firmly Within The 'Moderate Risk, High Reward' Portfolio Bucket

Feb 11

Calumet Specialty Products: Falling Knifes And Investor Irrationality

Jan 29

Calumet Specialty Products Blasted Off, The Cash Flow Went Solar

Aug 19

Calumet Specialty Q2 2022 Earnings Preview

Aug 04

The Final Countdown For Calumet Specialty Products' Launch Continues

Jul 29

It's The Final Countdown For Calumet Specialty Products

May 16

Calumet Specialty Products Partners, L.P. Always Landing On Its Feet

Mar 07

Evaluating Calumet's Apparent Conservative Equity Valuation

Jan 28

Calumet Specialty Products Calls All Aboard

Dec 08

Frantic Buying At Calumet Specialty Products

Oct 21

For Calumet, Progress Marches

Sep 01

More About Calumet's Duo Threaded Growth Businesses

Jun 16

Calumet Specialty EPS misses by $1.25, beats on revenue

May 07

Calumet's Critical Fundaments Continue To Improve, Significantly

Jan 30

Calumet makes Borgmann permanent CFO, lifting interim role

Jan 07

Calumet Specialty EPS misses by $0.11, beats on revenue

Nov 06

Navigating Calumet's Crossroads

Nov 02

Financial Position Analysis

Short Term Liabilities: CLMT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: CLMT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: CLMT has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: CLMT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Debt Coverage: CLMT's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: CLMT's interest payments on its debt are not well covered by EBIT (1.2x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.